These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
349 related items for PubMed ID: 17703138
1. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice. Preusch MR, Bea F, Yang SH, Kreuzer J, Isermann B, Pedal I, Rosenfeld ME, Katus HA, Blessing E. J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138 [Abstract] [Full Text] [Related]
2. Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice. Bea F, Kreuzer J, Preusch M, Schaab S, Isermann B, Rosenfeld ME, Katus H, Blessing E. Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2787-92. PubMed ID: 16990551 [Abstract] [Full Text] [Related]
3. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice. Desai A, Zhao Y, Warren JS. Cardiovasc Pathol; 2008 Dec; 17(4):233-40. PubMed ID: 18402814 [Abstract] [Full Text] [Related]
4. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice. Jacob S, Laury-Kleintop L, Lanza-Jacoby S. J Surg Res; 2008 May 01; 146(1):135-42. PubMed ID: 17950326 [Abstract] [Full Text] [Related]
5. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Yoshii T, Iwai M, Li Z, Chen R, Ide A, Fukunaga S, Oshita A, Mogi M, Higaki J, Horiuchi M. Hypertens Res; 2006 Jun 01; 29(6):457-66. PubMed ID: 16940709 [Abstract] [Full Text] [Related]
6. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis. Nachtigal P, Pospisilova N, Pospechova K, Jamborova G, Kopecky M, Jaynes R, Briestensky J, Santar I, Smahelova A, Solichova D, Zdansky P, Semecky V. Life Sci; 2006 Mar 20; 78(17):1983-9. PubMed ID: 16305803 [Abstract] [Full Text] [Related]
7. Dealcoholised beers reduce atherosclerosis and expression of adhesion molecules in apoE-deficient mice. Martinez N, Urpi-Sarda M, Martinez-Gonzalez MA, Andres-Lacueva C, Mitjavila MT. Br J Nutr; 2011 Mar 20; 105(5):721-30. PubMed ID: 21134332 [Abstract] [Full Text] [Related]
8. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice. Koga M, Kai H, Yasukawa H, Kato S, Yamamoto T, Kawai Y, Kusaba K, Seki Y, Kai M, Egashira K, Kataoka Y, Imaizumi T. Hypertens Res; 2007 Mar 20; 30(3):259-67. PubMed ID: 17510508 [Abstract] [Full Text] [Related]
11. Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis. Sievers P, Uhlmann L, Korkmaz-Icöz S, Fastner C, Bea F, Blessing E, Katus HA, Preusch MR. Drug Des Devel Ther; 2015 Mar 20; 9():3935-42. PubMed ID: 26251572 [Abstract] [Full Text] [Related]
12. Antiatherogenic effect of antioxidant polyphenols from Phellinus baumii in apolipoprotein E-deficient mice. Noh JR, Lee IK, Kim YH, Gang GT, Hwang JH, Ly SY, Yun BS, Lee CH. Ann Nutr Metab; 2011 Mar 20; 59(2-4):145-53. PubMed ID: 22142871 [Abstract] [Full Text] [Related]
13. Nicotinic acid has anti-atherogenic and anti-inflammatory properties on advanced atherosclerotic lesions independent of its lipid-modifying capabilities. Holzhäuser E, Albrecht C, Zhou Q, Buttler A, Preusch MR, Blessing E, Katus HA, Bea F. J Cardiovasc Pharmacol; 2011 Apr 20; 57(4):447-54. PubMed ID: 21242806 [Abstract] [Full Text] [Related]
18. Protocatechuic acid, a metabolite of anthocyanins, inhibits monocyte adhesion and reduces atherosclerosis in apolipoprotein E-deficient mice. Wang D, Wei X, Yan X, Jin T, Ling W. J Agric Food Chem; 2010 Dec 22; 58(24):12722-8. PubMed ID: 21090717 [Abstract] [Full Text] [Related]